NCT06162689

Brief Summary

The goal of this observational study is to examine the relationship between severe perinatal maternal mental illness and stress reactivity and general development of children aged 6 to 8 years. Mothers were previously recruited and assessed during pregnancy and their babies were assessed at 6 days, 8 weeks and 12 months post delivery. This follow-up will assess the occurrence of any psychiatric episodes (e.g., depression, mania, psychosis) in the intervening period. Assessments of the children will include evaluation of their response to a mildly stressful procedure, as well as their physical, cognitive and social-emotional development, and their mental health. Possible factors that may moderate the relationship between the mother's perinatal mental health and the child's stress reactivity and development, including the home environment, adversity, parent-child interaction and maternal and paternal (or co-parent) mental health will also be assessed.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
201

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

November 15, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

December 8, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 9, 2025

Status Verified

March 1, 2025

Enrollment Period

2.1 years

First QC Date

March 27, 2023

Last Update Submit

September 2, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Child Salivary Cortisol

    Child stress response - salivary cortisol: saliva samples will be collected before and after a mild stressor test: Cold Pressor Test (CPT) to assess stress reactivity.

    6-8 years

  • Child Salivary Cortisol

    Child stress response - salivary cortisol: saliva samples will be collected before and after a mild stress test: MacArthur Story Stem battery (MSSB) to asses stress reactivity

    6-8 years

Secondary Outcomes (13)

  • Wechsler Intelligence Scale for Children (4th Edition) (WISC-IV)

    6-8 years

  • Wechsler Individual Achievement Test Second UK Edition (WIAT-II UK)

    6-8 years

  • Dimensional Change Card Sort Test (DCCS)

    6-8 years

  • Depression Self-Rating Scale (DSRS)

    6-8 years

  • State-Trait Anxiety Inventory for Children (STAIC)

    6-8 years

  • +8 more secondary outcomes

Study Arms (2)

Exposed Group

Women at risk of postpartum psychosis during pregnancy

Unexposed Group

Women with no current or past history of psychiatric disorders during pregnancy

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study comprised 2 groups: women at risk of postpartum psychosis during pregnancy (exposed group) and women with no current or past history of psychiatric disorders (unexposed group). Cases were women at risk of postpartum psychosis because of a DSM-IV diagnosis of bipolar disorder, schizoaffective disorder or previous postpartum psychosis and controls were women who did not have a current or past history of psychiatric disorders. Clinical assessments were undertaken in the second and third trimesters of pregnancy and, following delivery, assessments of mother and infant were undertaken at 6 days, 8 weeks and 12 months post-delivery (n=72). At this stage, participants were asked to provide written consent to be contacted in the future about the possibility of taking part in a follow-up study.

You may qualify if:

  • Women who participated in the previous study (Risk factors of perinatal mental disorders: Stress, electrophysiological, and neuroimaging markers), who gave consent to be contacted again, together with their offspring, and the child's father/co-parent.

You may not qualify if:

  • Women who participated in the previous study who refused consent to be contacted again.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King's College London

London, SE5 8AF, United Kingdom

Location

Biospecimen

Retention: SAMPLES WITH DNA

Saliva samples from adult participants and their children to assess salivary cortisol. Blood serum is collected from participants for the assessment of inflammatory markers and transcriptomic analysis.

Study Officials

  • Paola Dazzan, MD MSc PhD FRCPsych

    King's College London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2023

First Posted

December 8, 2023

Study Start

November 15, 2023

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

September 9, 2025

Record last verified: 2025-03

Locations